• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WHELE LLC / CHENGDU SHIFENG MEDICAL TECHNOLOGY CO., LTD. CARTRIDGE 3ML RG MEDICATION; ACCESSORIES, PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WHELE LLC / CHENGDU SHIFENG MEDICAL TECHNOLOGY CO., LTD. CARTRIDGE 3ML RG MEDICATION; ACCESSORIES, PUMP, INFUSION Back to Search Results
Lot Number 10-210720
Device Problems Device Alarm System (1012); Inaccurate Delivery (2339)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/05/2022
Event Type  malfunction  
Event Description
Inbound; pt reports treprostinil ms3 pump alarming low volume when medication remains in cartridge.Pump alarms low volume at 48 hrs instead of usual 72 hrs.Alarms with generic cadd ms3 3 ml cartridge.Rg3 cartridge syringe lot number 10-210408, exp "20260407" and rg3 cartridge syringe lot number 10-210720, exp 07/19/2023.No further details provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTRIDGE 3ML RG MEDICATION
Type of Device
ACCESSORIES, PUMP, INFUSION
Manufacturer (Section D)
WHELE LLC / CHENGDU SHIFENG MEDICAL TECHNOLOGY CO., LTD.
MDR Report Key13282881
MDR Text Key284107665
Report NumberMW5106699
Device Sequence Number2
Product Code MRZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 01/05/2022
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Date FDA Received01/14/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Lot Number10-210720
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Treatment
TREPROSTINIL
Patient Age50 YR
Patient SexFemale
-
-